VACCINES

vaccines

In this series which will probably be about 10 parts I am going to talk about vaccines. There is much to know about development of a vaccine and I am going to try to break it down. As in my other posts you have to read these in sequence to get the most out of it.

Here is the description of all the sections and every day you will be introduced to one section.

Part  1 – Approaches (Platforms) for development of a COVID-19 vaccine

              Will discuss the different types of vaccines, benefits and challenges

Part  2 – The phases of vaccine trials

              Will discuss the three phases of vaccine development and the rationale for them

Part 3 – The current players in the vaccine development landscape

              Will discuss the companies and their support systems

Part 4 – The Oxford Group and Astrazeneca (UK)

              Will discuss the type of vaccine, the animal studies and human trials

Part 5- NIH group and Moderna  (USA)

             Will discuss the type of vaccine, the animal studies and human trials

Part 6 – Sinovac (CHINA)

              Will discuss the type of vaccine, the animal studies and human trials

Part 7 – Ethical considerations (challenge studies)

             Will discuss the framework for challenge studies in healthy volunteers, the     

             benefits and risks

Part 8 – My own reflections on this topic

Stay tuned and share as you wish

Location

ARLINGTON VA

2800 Shirlington Road Suite 100
Arlington VA 22206

Phone: (703) 844-7770
Fax : 703-866-3133